TBC1D4 antibody (C-Term)
Quick Overview for TBC1D4 antibody (C-Term) (ABIN6990834)
Target
See all TBC1D4 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 1190-1240, C-Term
-
Purification
- TBC1D4 Antibody is affinity chromatography purified via peptide column.
-
Immunogen
- TBC1D4 antibody was raised against an 19 amino acid peptide near the carboxy terminus of human TBC1D4 . The immunogen is located within amino acids 1190 - 1240 of TBC1D4.
-
Isotype
- IgG
-
-
-
-
Application Notes
-
TBC1D4 antibody can be used for immunohistochemistry starting at 10 μ,g/mL.
Antibody validated: Immunohistochemistry in human samples. All other applications and species not yet tested. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- TBC1D4 Antibody is supplied in PBS containing 0.02 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,4 °C
-
Storage Comment
- TBC1D4 antibody can be stored at 4°C for three months and -20°C, stable for up to one year.
-
-
- TBC1D4 (TBC1 Domain Family, Member 4 (TBC1D4))
-
Alternative Name
- TBC1D4
-
Background
- TBC1D4 Antibody: TBC1D4, also known as the Akt substrate AS160, was initially identified as an Akt substrate containing a GTPase-activating domain that regulates GLUT4 trafficking, with activation following insulin stimulation. TBC1D4 truncations in humans is a major cause of dominant inherited insulin resistance. The loss of TBC1D4 results in the accumulation of GLUT4 in compartments that are primed for fusion in basal adipocytes.
-
Molecular Weight
-
Predicted: 143 kDa
Observed: 140 kDa -
Gene ID
- 9882
-
NCBI Accession
- NP_055647
-
UniProt
- O60343
Target
-